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Communication about colorectal cancer screening in Britain:
public preferences for an expert recommendation
J Waller1, A Macedo1, C von Wagner1, AE Simon1,2, C Jones1, V Hammersley3, D Weller3, J Wardle*,1,4
and C Campbell3,4
1Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, Gower Street, London WC1E 6BT, UK;
2School of Health Sciences, City University London, College Building, Northampton Square, London EC1V 0HB, UK; 3Centre for Population Health
Sciences, The University of Edinburgh, Medical Quad, Teviot Place, Edinburgh, EH8 9AG, Scotland, UK
BACKGROUND: Informed decision-making approaches to cancer screening emphasise the importance of decisions being determined by
individuals’ own values and preferences. However, advice from a trusted source may also contribute to autonomous decision-making.
This study examined preferences regarding a recommendation from the NHS and information provision in the context of colorectal
cancer (CRC) screening.
METHODS: In face-to-face interviews, a population-based sample of adults across Britain (n¼ 1964; age 50–80 years) indicated their
preference between: (1) a strong recommendation to participate in CRC screening, (2) a recommendation alongside advice to make
an individual decision, and (3) no recommendation but advice to make an individual decision. Other measures included trust in the
NHS and preferences for information on benefits and risks.
RESULTS: Most respondents (84%) preferred a recommendation (47% strong recommendation, 37% recommendation plus individual
decision-making advice), but the majority also wanted full information on risks (77%) and benefits (78%). Men were more in favour of
a recommendation than women (86% vs 81%). Trust in the NHS was high overall, but the minority who expressed low trust were
less likely to want a recommendation.
CONCLUSION: Most British adults want full information on risks and benefits of screening but they also want a recommendation from
an authoritative source. An ‘expert’ view may be an important part of autonomous health decision-making.
British Journal of Cancer (2012) 107, 1938–1943. doi:10.1038/bjc.2012.512 www.bjcancer.com
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Historically, the emphasis in public health research on cancer
screening has been on maximising uptake. However, actively
encouraging participation can sit uncomfortably with the con-
temporary emphasis on promoting informed choice in health
decision-making (Raffle, 2001; Jepson et al, 2005). In some
countries, shared decision-making can take place in a primary care
consultation before screening (Miles A. et al, 2004; Zapka and
Lemon, 2004; Price et al, 2010; Zapka et al, 2011), but in the UK,
which has an organised programme of cancer screening (NHS,
2012), information is mailed out with screening invitations, and the
decision about whether to participate must be made by the
individual. Although there is some variation between the breast,
cervical and bowel screening programmes, and between the nations
of the UK, in general the programmes encourage people to use the
information provided to weigh up the pros and cons of screening.
Does informed choice necessarily exclude an expert (provider)
recommendation? A recent framework on screening communication
identified three approaches (Entwistle et al, 2008). As well as the two
extremes: ‘be screened’ (a clear recommendation) and ‘analyse and
choose’ (the individual should weigh up risks and benefits and make
their own decision), an intermediate position was identified, termed
‘consider an offer’, which provides a recommendation but
encourages people to consider the trustworthiness of the source
(Entwistle et al, 2008). This recognises both participation and non-
participation as legitimate decisions and is potentially compatible
with trying to maximise informed uptake while respecting personal
autonomy. It is similar to the libertarian paternalist perspective that
provides a default recommendation along with information allowing
the individual to decline the default (Wheeler et al, 2011). As long as
the source is clear, the individual should be able to evaluate the
trustworthiness of both the recommendation and the information. A
recommendation from a trusted source allows individuals to engage
in ‘intellectual outsourcing’ (Appiah, 2005), consistent with the
notion of ‘bounded rationality’ (Simon, 1957), rather than having to
evaluate all the information themselves.
Little is known about public preferences for having an expert/
provider recommendation to take part in screening, although the
limited evidence available suggests it may be valued (Østerlie et al,
2008; Woodrow et al, 2008). This could be particularly true for
individuals who lack the numeracy skills to evaluate statistical
detail about risks and benefits of participation (Reyna et al, 2009;
Peters, 2012). Lower socioeconomic status (SES) groups in the US
report less confidence in their ability to deal with statistical
information (Smith et al, 2010a). In addition, an Australian study
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carried out in a population with low levels of education found that
a decision aid (DA) designed to promote autonomous decision-
making about colorectal cancer (CRC) screening increased
informed decision making by 22% but reduced uptake by 16%
(Smith et al, 2010b).
In this study, we assessed public preferences for a recommenda-
tion in the context of the National Health Service (NHS) Colorectal
(Bowel) Cancer Screening Programme in the UK asking
respondents to express a preference between: (i) a strong
recommendation to take part in faecal occult blood testing, (ii) a
recommendation plus advice to make an individual choice, or (iii)
no recommendation but advice to make an individual decision. We
also assessed trust in the NHS and desire for information on risks
and benefits. We hypothesised that preference for a recommenda-
tion would be associated with higher trust, lower desire for
information about risks and benefits and lower SES.
METHODS
Data were collected as part of a population-based survey carried
out by TNS Research International in July 2011. The omnibus
survey included questions from a range of contributors on a
variety of non-health-related issues. A description of the survey,
including questions and response scales, is provided in the
supplementary material. The sample included 2067 men and
women, aged 50–80 years, living in Great Britain. The majority of
people in this age group would either have been invited for CRC
screening or be approaching the age of their first invitation (faecal
occult blood is offered between 60 and 69 years in England,
between 50 and 74 in Scotland and between 60 and 71 in Wales)
(NHS, 2011; NHS Cancer Screening Programmes, 2011; NHS
Wales, 2011).
Data were collected using home-based, computer-assisted
personal interviewing; a methodology commonly used in similar
studies (e.g., Robb et al, 2009; Beeken et al, 2011), in which
questions are administered as an interview, and the interviewer
enters responses directly into a laptop computer. Where response
options are long or complicated, the interviewee is able to look at
the screen in order to choose a response. Random location
sampling was used to select sample points from the 2001 Census
small-area statistics and the postcode address file, stratified
by Government Office Region and social grade. At each location,
quotas were set for age, gender, children in the home and working
status.
Measures
Preferences for level of provider recommendation Informed by
previous work, including that of Entwistle et al (2008), three
options were designed to vary in the level of explicit recommenda-
tion accompanying the screening invitation. The question wording
was as follows: ‘Now I would like you to think about if you were
being invited to take part in bowel cancer screening as part of the
NHS screening programme. In the information you receive from
the NHS, would you prefer: (i) no recommendation—it’s up to you
to decide whether to do the test or not, (ii) a statement that the
NHS thinks you should do the test, but that it’s up to you to decide,
(iii) a strong recommendation from the NHS to do the test.’
Desire for information Respondents reported how much infor-
mation on benefits of screening they wanted, on a scale from 1
(‘no information’) to 10 (‘all the information currently available’).
The same question was asked on risks. Due to the skewed
distribution, responses were recoded into 1–5 (‘low’); 6–8
(‘medium’); and 9–10 (‘high’).
Trust in the NHS Respondents were asked to indicate their
agreement (on 5-point Likert scales) to two questions adapted
from the Health Information National Trends Survey (U.S.National
Institutes of Health, 2011). The text said: ‘Most screening tests have
potential risks as well as benefits. How much do you agree or
disagree with the following statements: (i) I trust the NHS to decide
whether a screening test is worth having; (ii) If the NHS is offering
me a screening test, it must be safe’. Responses were recoded into
‘agree/strongly agree’; ‘neither agree nor disagree’; and ‘disagree/
strongly disagree’.
Sociodemographic factors We recorded gender, age, country of
residence, social grade (as a marker of SES) and marital status.
Social grade was based on occupation (or previous occupation if
receiving an occupational/private pension), using a classification
frequently applied in market research: AB (high or intermediate
managerial, administrative or professional occupations); C1
(supervisory, clerical or junior managerial, administrative or
professional occupations); C2 (skilled manual workers); and
DE (semi-skilled or unskilled manual workers, state pensioners
or causal/lowest grade workers and those reliant on state benefits).
People who were not working were classified according to the chief
wage earner in the household.
All questions were pre-tested for clarity and ease of response
using cognitive interviewing techniques (n¼ 10), and the wording
was adjusted where necessary.
Analysis
After descriptive analyses, we used ordinal logistic regression to
explore associations between level of screening recommendation
preference and (i) trust in the NHS, (ii) desire for information on
risks and benefits, and (iii) social grade. Analyses were adjusted for
other demographic factors. The outcome variable was ordered into
(1) no recommendation, (2) consider a recommendation, and (3) a
strong recommendation. Adjusted odds ratios (ORs) and 95%
confidence intervals (CI) are presented, with a significance level of




Respondents (n¼ 103) who did not answer the question on
recommendation preference were excluded from the analyses,
leaving a sample of 1964 (see Table 1a). Respondents were
predominantly white (96%), with the proportions from England,
Scotland and Wales matching the population sizes of the three
countries (84, 11, and 5%, respectively). There was a balanced
distribution by age and gender. More respondents were in the
lowest social grade (DE¼ 37%) than the others (AB¼ 20%,
C1¼ 23%, C2¼ 20%), partly due to state pensioners being
included in this group. Most respondents were married or living
as married (62%).
Information, trust and recommendations
The majority of respondents (84%) preferred a recommendation to
take part in the CRC screening programme rather than being
expected to make the decision entirely themselves. Most (47%)
preferred to receive a strong recommendation from the NHS to
take part in CRC screening, 37% preferred to consider a
recommendation to do the test and only 16% preferred not to
have an explicit recommendation (see Table 1a).
Overall, respondents reported high levels of trust in the NHS,
both in terms of being able to ‘decide whether a screening test is
worth having’ (79%) and believing that a test offered by the NHS
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‘must be safe’ (76%). Only 9% and 10%, respectively, disagreed
with these two statements. However, high trust did not preclude an
equally strong desire to be fully informed, with nearly 4 in 5
respondents wanting to receive full information (selecting 9 or 10
on the scale of 1–10) on benefits (78%) and risks (77%) of
screening.
Low desire for information on benefits and risks (1–5 on the
response scale) was associated with lower social grade (benefits:
X2(3)¼ 20.5, Po0.001; risks: X2(3)¼ 8.5, P¼ 0.04), although
overall desire for information was high across groups. In the
lowest social grade (DE), 9% of people had low desire for
information on benefits, compared with 3% of people in the
highest grade (AB). The equivalent figures for low desire for
information on risks were 10% (DE) and 5% (AB). Living in
Scotland rather than the other two countries was also associated
with lower desire for information (benefits: X2(2)¼ 16.0, Po0.001;
risks: X2(2)¼ 8.5, P¼ 0.02).
Predictors of recommendation preferences
As shown in Table 1b, respondents who did not trust the NHS were
less likely to prefer a recommendation (OR: 0.68, 95% CI: 0.54–
0.85, P¼ 0.001). Somewhat paradoxically, those who wanted less
information on the benefits of the test were also less likely to want
a recommendation (medium information: OR: 0.67, 95% CI: 0.53–
0.85, P¼ 0.001; low information: OR: 0.68, 95% CI: 0.47–0.98,
P¼ 0.04). Desire for information on risks did not show a
consistent association with preference for a recommendation.
Contrary to our prediction, social grade was not associated with
recommendation preference. Of the other five socio-demographic
and geographic variables (see Table 1a), men were more likely
than women to prefer a recommendation (OR: 1.25, 95% CI:
1.09–1.42, P¼ 0.001) and respondents who were single were less
likely to prefer a recommendation than the married group
(OR: 0.74, 95% CI: 0.60–0.93, P¼ 0.008). Respondents in Scotland
and Wales were more likely to prefer a recommendation than
those in England (OR: 1.63, 95% CI: 1.31–2.07, Po0.001 and OR:
1.43, 95% CI: 1.06–1.95, P¼ 0.02 for Scotland and Wales,
respectively).
DISCUSSION
This study found widespread preference for a recommendation
from the NHS to take part in CRC screening, with 84% of
respondents wanting either a strong recommendation to partici-
pate (47%) or a recommendation alongside individual choice
(37%). This is consistent with findings in Norway where women
welcomed the ‘paternalistic’ provision of mammography appoint-
ments (Østerlie et al, 2008), and qualitative research in the UK
showing that people wanted faecal occult blood test information to
promote participation strongly (Woodrow et al, 2008).
Despite preference for a recommendation, there was also a
desire for full information about risks and benefits. A recommen-
dation was seen as an adjunct to information, not an alternative,
and respondents who preferred a recommendation expressed a
desire for more information on the benefits of screening. This









choosing a higher level of
recommendation
(n¼ 1877)
n (%) OR (95% CI)
All (n¼ 1964) 323 (16.4) 723 (36.8) 918 (46.7)
Gender
Female (n¼ 1021) 189 (18.5) 389 (38.1) 443 (43.3) Reference
Male (n¼ 943) 134 (14.2) 334 (35.4) 475 (50.4) 1.25 (1.09-1.42)**
Age, years
50–59 (n¼ 669) 102 (15.2) 262 (39.2) 305 (45.6) Reference
60–69 (n¼ 657) 102 (15.5) 242 (36.8) 313 (47.6) 1.03 (0.88-1.21)
70–80 (n¼ 638) 119 (18.7) 219 (34.3) 300 (47.0) 0.94 (0.80-1.10)
Country
England (n¼ 1645) 278 (16.9) 634 (38.5) 733 (44.6) Reference
Scotland (n¼ 213) 31 (14.6) 57 (26.8) 125 (58.7) 1.63 (1.31-2.07)***
Wales (n¼ 106) 14 (13.2) 32 (30.2) 60 (56.6) 1.43 (1.06-1.95)*
Social grade
AB (high; n¼ 402) 60 (14.9) 164 (40.8) 178 (44.3) Reference
C1 (n¼ 462) 76 (16.5) 167 (36.1) 219 (47.4) 1.11 (0.92-1.34)
C2 (n¼ 399) 52 (13.0) 144 (36.1) 203 (50.9) 1.16 (0.95-1.41)
DE (low; n¼ 701) 135 (19.3) 248 (35.4) 318 (45.4) 1.03 (0.87-1.25)
Marital status
Married (n¼ 1217) 175 (14.4) 452 (37.1) 590 (48.5) Reference
Single (n¼ 178) 36 (20.2) 78 (43.8) 64 (36.0) 0.74 (0.60-0.93)**
Widowed/divorced/separated
(n¼ 569)
112 (19.7) 193 (33.9) 264 (46.4) 0.96 (0.83-1.12)
Abbreviations: CI¼ confidence interval; OR¼ odds ratio adjusted for all measures in Tables 1a and 1b. *Po0.05, **Po0.01, ***Po0.001. Percentages may not add up to 100%
due to rounding. Percentages are not adjusted. Total ns may vary due to missing data.
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could be seen as paradoxical—people wanting to make their own
decisions requiring less information to do so, and further research
is needed to understand why this might be. Alternatively, people
who want a recommendation might feel that full information,
particularly about the benefits, is needed to explain why a
recommendation is being made. Whether people who want
information always read or understand it is a different issue
(Jepson et al, 2005); balanced information may be valued in itself,
rather than necessarily reflecting an intention to use the
information in decision-making. The information leaflet may
simply be held in reserve in case of need; as with information
leaflets provided with medicines (Jepson et al, 2007).
Preference for a recommendation could be interpreted as
consistent with the notion of ‘intellectual outsourcing’ (Appiah,
2005), which recognises that no one can be fully autonomous in all
decisions, and in some circumstances, it is appropriate to rely on a
trusted other to provide advice rather than engaging with the
information personally. Across most areas of life, from finance to
plumbing, people recognise that others’ expertise is critical, and
the key is to find a trusted source. In the UK screening context,
trust in the NHS was significantly associated with preference for a
recommendation. In this sample, most respondents reported high
levels of trust, but the small proportion (9%) with low trust were
more likely to want to make a decision without a recommendation.
This fits with the emphasis on evaluating the trustworthiness of the
source of an offer in the ‘consider an offer’ approach (Entwistle
et al, 2008).
Men were more likely than women to prefer a recommendation,
and single people were less likely than married people to want a
recommendation. Although differences in screening uptake by
gender and marital status have been found previously (Seeff et al,
2004; van Jaarsveld et al, 2006; von Wagner et al, 2011), it is not
clear how recommendation preferences might interact with
approaches to screening communication to affect participation.
Our findings suggest that primary care interactions relating to
screening may need to be tailored to the demographic character-
istics of the individual patient.
Previous research has shown SES differences in awareness of the
purpose of screening or its effects (James et al, 2008; Orbell et al,
2008; Beeken et al, 2011), but the present results, using social grade
as a marker of SES, showed no evidence that this translates into
differences in recommendation preferences. However, concern
remains that evaluating complex information in order to reach an
informed decision might be more problematic to those from
socially disadvantaged backgrounds (Raffle, 2001), and there
remain challenges to achieving informed decision-making across
all groups. Even when information materials are specifically
designed for low-literacy groups, it can be difficult to facilitate
informed decision-making. The DA used by Smith et al (2010b)
was carefully developed to be clear and easy to read, but only a
third of the intervention group made an informed decision about
screening, and the mean knowledge score, though higher in the DA
arm than the control group, was only 6.5 out of 12. Qualitative
work associated with the trial indicated that some participants did
not understand the purpose of the DA and others felt overloaded
by risk information and statistics (Smith et al, 2012). Future work
might benefit from more fine-grained analysis of the specific
aspects of screening knowledge that are associated with different
behavioural outcomes.
Another study found no evidence that DAs reduce participation
in CRC screening (Steckelberg et al, 2011); however, the mean
knowledge score was also around 50% in the DA group,
confirming the difficultly of achieving very high knowledge. In
our study, there was some evidence that lower SES groups were
less likely to want information about the risks and benefits of
screening, although overall it should be noted that desire for
information was high across all the groups. Given the differential
uptake of CRC screening by SES in the UK (von Wagner et al,









choosing a higher level of
recommendation (n¼ 1877)
n (%) OR (95% CI)
All (n¼ 1964) 323 (16.4) 723 (36.8) 918 (46.7)
Desire for information on risks and benefits
How much information should a screening leaflet have about the benefits?
9–10 (high; n¼ 1553) 240 (15.9) 540 (35.8) 727 (48.2) Reference
6–8 (medium; n¼ 325) 45 (14.7) 138 (45.1) 123 (40.2) 0.67 (0.53-0.85)**
1–5 (low; n¼ 112) 25 (24.3) 34 (33.0) 44 (42.7) 0.68 (0.47-0.98)*
How much information should a screening leaflet have about the risks?
9–10 (high; n¼ 1528) 244 (16.5) 538 (36.4) 697 (47.1) Reference
6–8 (medium; n¼ 301) 36 (12.5) 121 (42.0) 131 (35.5) 1.34 (1.04-1.71)*
1–5 (low; n¼ 158) 29 (19.7) 49 (33.3) 69 (46.9) 1.29 (0.94-1.77)
Trust in the NHS
I trust the NHS to decide whether a screening test is worth having.
Strongly agree/agree (n¼ 1610) 224 (14.4) 562 (36.2) 766 (49.4) Reference
Neither agree nor disagree (n¼ 237) 49 (22.0) 96 (43.0) 78 (35.0) 0.71 (0.59-0.86)**
Strongly disagree/disagree (n¼ 183) 46 (26.7) 59 (34.3) 67 (39.0) 0.68 (0.54-0.85)**
If the NHS is offering me a test, it must be safe.
Strongly agree/agree (n¼ 1542) 224 (15.1) 534 (36.1) 723 (48.8) Reference
Neither agree nor disagree (n¼ 281) 54 (20.0) 111 (41.1) 105 (38.9) 0.83 (0.69-0.99)*
Strongly disagree/disagree (n¼ 203) 42 (21.8) 72 (37.3) 79 (40.9) 0.94 (0.75-1.17)
Abbreviations: CI¼ confidence interval; OR¼ Odds ratio adjusted for all measures in Tables 1a and 1b. *Po0.05, **Po0.01, ***Po0.001. Percentages may not add up to
100% due to rounding. Percentages are not adjusted. Total ns may vary between variables due to missing data.
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2011), more research is urgently needed to explore interactions
between SES, knowledge acquisition and screening uptake.
Strengths and limitations
To our knowledge, this is the first study to ask the public what
type of screening recommendation they want or how much
information on benefits and risks they would like. The study
benefited from a large national sample of adults in Britain,
although in line with the population distribution across the UK
nations, most respondents were from England (84%). The
proportion of non-white respondents reflected population demo-
graphics and was therefore too small to allow comparisons by
ethnic group. It is well-established that screening participation
varies by ethnic group (Moser and Patnick, 2009; CDC, 2012), so
further investigation of recommendation preferences in non-white
groups should be a priority for future research. By using an
omnibus survey that included questions from other organisations
on non-health-related topics, we reduced the likelihood that
participation would have been biased by factors affecting
responses to the questions reported here. The question on
preferences for a recommendation was framed within the context
of CRC screening and the outcome could be different for other
types of cancer screening. In addition, future work would benefit
from the development of more comprehensive measures to assess
other aspects of the Entwistle et al (2008) approach. Finally, we
used an occupational indicator of SES, and this might be a reason
for the lack of association between SES and recommendation
preference.
Policy implications and future research
These results support UK policies that provide full information on
potential benefits and risks of screening tests as well as a
recommendation from the NHS to attend screening. This approach
has recently been adopted in Scotland (NHS, 2011) and fits with
current UK government policy to ‘empower the greatest number
possible from all groups and communitiesy to make an informed
choice to participate in cancer screening’ (Department of Health
(UK), 2011, our italics). ‘Consider an offer’ may help reduce the
tension between an explicit informed choice approach and an
implicit aim to maximise coverage. These findings are particularly
timely given the current review of information materials used
within the NHS cancer screening programmes (Richards, 2011),
although this survey was carried out before the announcement
of this and the associated review of mammography provision.
‘Consider an offer’ provides a way to communicate about
cancer screening that reduces the decision-making burden while
still promoting autonomous decision-making (Entwistle et al,
2008), although further research is needed to establish how
best to provide the combination of a recommendation and
information on risks and benefits (Perneger et al, 2011).
Qualitative research might be useful in further understanding
the reasons for people’s information preferences and the ways
in which information provided with a screening invitation is
actually used.
In the future, we may want to work towards educating the
public, as healthcare users, about the evolving nature of the
evidence-base for cancer screening; hence the need for informed
decisions based on individual circumstances. For some patients,
this may require working through a decision-making process with
the primary care physician so that factors such as co-morbidities
are discussed before a negotiated ‘recommendation’ can be
reached (Weller et al, 2009); an approach that will rely on health
professionals in primary care settings being up-to-date with
national screening guidelines.
Future research could build on these results with more nuanced
questions on information and recommendation preferences that
could address public understanding of the constraints placed on
healthcare providers in the extent of recommendation they can
provide given the imperative of basing advice on the best available
evidence. In addition, attitudes to communication about other
screening modalities could be explored, particularly in the context
of screening tests where the evidence for efficacy is contested, such
as prostate-specific antigen testing and, increasingly, mammogra-
phy (Gomella et al, 2011; van Ravesteyn et al, 2012), where any
kind of ‘nudge’ to take part could be seen as inappropriate (Ploug
et al, 2012).
CONCLUSION
Most British adults want full information on risks and benefits
of screening but they also want a recommendation from
an authoritative source. This supports the ‘consider an
offer’ approach within which an ‘expert’ view from a trusted
source may be an important part of autonomous health
decision-making.
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